Corinne Hoff
Geen lopende functies
Profiel
Ms. Corinne Hoff is a Director-Communications & Investor Relations at Exonhit.
Ms. Hoff was previously employed as Leiter Finanzielle Medienverhältnisse by Novartis AG.
Eerdere bekende functies van Corinne Hoff
| Bedrijven | Functie | Einde |
|---|---|---|
Exonhit
 Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Public Communications Contact | 20-12-2012 |
| NOVARTIS AG | Public Communications Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NOVARTIS AG | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
